The departments of Health and Human Services and Defense will pay Janssen Pharmaceutical Companies of Johnson & Johnson $1 billion to manufacture 100 million doses of its COVID-19 vaccine candidate for use in clinical trials, or to vaccinate Americans if authorized by the Food and Drug Administration.

Under the agreement, the government also could acquire additional doses to vaccinate up to 300 million people, the agencies said.

Related News Articles

Headline
U.S. residents can order online eight more free at-home tests for COVID-19, the White House announced yesterday. People who have difficulty accessing the…
Headline
The Food and Drug Administration today authorized a single Pfizer COVID-19 booster dose for children aged 5-11 who completed the Pfizer vaccine primary series…
Headline
A recent op-ed in the online publication STAT contains “blatant factual inaccuracies” and omits critical information about hospital and health systems’…
Blog
A recent op-ed in the online publication STAT (Turn off the spigot for hospitals’ COVID-19 relief funding) contains blatant factual inaccuracies but also omits…
Headline
The Health Resources and Services Administration has extended to May 18 the deadline for health care providers who received Provider Relief Fund payments…
Perspective
Yesterday, our country surpassed a grim and somber milestone: 1 million COVID-19 deaths in the U.S.. America’s hospitals and health systems — and their…